A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christian F. Meyer, MD, PhD, MS
Johns Hopkins University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Cancer Centre
Toronto, Ontario, Canada
- Centre Leon Berard
Lyon, France
- Helios Klinikum Bad Saarow
Bad Saarow, Germany
- Universitäres Krebszentrum (uccl)
Leipzig, Germany
- Hospital Universitari Vall Hebron
Barcelona, Spain
- Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
- Centro Integral Oncologico Clara Campal (hm Ciocc)
Madrid, Spain
- Usc/norris Comprehensive Cancer Center
Los Angeles, California, United States
- Sarcoma Oncology Center
Santa Monica, California, United States
- University of California Los Angeles (ucla) - Santa Monica Cancer Care
Santa Monica, California, United States
- Yale School of Medicine - Smilow Cancer Hospital - Yale - New Haven Hospital Location
New Haven, Connecticut, United States
- Profound Research Llc
Farmington Hills, Michigan, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Duke Cancer Center
Durham, North Carolina, United States
- the James Cancer Hospital and Solove Research Institute
Columbus, Ohio, United States
- Temple University - Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
- University of Pennsylvania - Abramson Cancer Center
Philadelphia, Pennsylvania, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Jun 2024
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2028
- Last update posted
- 29 Jul 2025
- Registered enrollment
- 333
- Registry id
- NCT06263231
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.